Intermedin A, a New Labdane Diterpene Isolated from Alpinia intermedia, Prolonged the Survival Time of P-388D₁ Tumor-Bearing CDF₁ Mice

Abstract

Eight ethanolic extracts of indigenous Taiwanese plants of the genus Alpinia were tested for tumor cytotoxicity against AGS, Hep G2, HeLa, KB, and HL-60 cells. Among the 50 % and 95 % EtOH extracts of eight Alpinia species, the cytotoxic effects of Alpinia intermedia leaves were the strongest. When the leaf extract of A. intermedia was partitioned using n-hexane and aqueous solvents, the n-hexane layer showed a greater cytotoxic effect and could prolong the survival time of P-388D₁ tumor-bearing CDF1 mice. Two new labdane diterpene derivatives, intermedin A (1) and intermedin B (2), and coronarin E (3) were isolated from the n-hexane layer of A. intermedia. Intermedin A induced apoptosis in HL-60 cells at 30 µg/mL and significantly prolonged the survival time of P-388D₁ tumor-bearing CDF₁ mice by 48.7 % at 20 mg/kg of body weight. We suggest that intermedin A is a major compound of A. intermedia and has a cytotoxic effect on HL-60 and P-388D₁ cells.

Key words

Alpinia intermedia - Zingiberaceae - intermedin A - apoptosis - P-388D₁ tumor-bearing CDF₁ mice

• References

• 1 Pezzuto JM. Plant-derived anticancer agents. Biochem Pharmacol 1997; 53: 121-133
• 2 Itokawa H, Morita H, Kobayashi T, Watanabew K, Iitaka Y. Novel sesquiterpenes from Alpinia intermedia Gagnep. Chem Pharm Bull (Tokyo) 1987; 35: 2860-2868
• 3 Tewari M, Quan LT, OʼRourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 1995; 81: 801-809
• 4 Surh YJ. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res 1999; 428: 305-327
• 5 Chen L, He F. Difference of pharmacokinetics and pharmacodynamics in optics drugs. Chinese Journal of New Drugs and Clinical Remedies 2003; 22: 377-380
• 6 Chen X, Li Y. Chiral drugs in the future. China Prescription Drug 2003; 8: 54-56
• 7 Sampaio EP, Sarno EN, Galilly R, Cohn ZA, Kaplan G. Thalidomide selectively inhibits tumor necrosis factor α production by stimulated human monocytes. J Exp Med 1991; 173: 699-703
• 8 Raje N, Anderson K. Thalidomide – a revival story. New Engl J Med 1999; 341: 1606-1608
• 9 Peuckmann V, Fisch M, Bruera E. Potential novel uses of thalidomide: focus on palliative care. Drugs 2000; 60: 273-292
• 10 Grilo LS, Carrupt PA, Abriel H. Stereoselective inhibition of the hERG1 potassium channel. Front Pharmacol 2000; 1: 137
• 11 Hedman A, Meijer DK. Stereoselective inhibition by the diastereomers quinidine and quinine of uptake of cardiac glycosides into isolated rat hepatocytes. J Pharm Sci 1998; 87: 457-461
• 12 Matsuda H, Morikawa T, Sakamoto Y, Toguchida I, Yoshikawa M. Labdane-type diterpenes with inhibitory effects on increase in vascular permeability and nitric oxide production from Hedychium coronarium . Bioorg Med Chem 2002; 10: 2527-2534
• 13 Sy LK, Brown GD. Labdane diterpenoids from Alpinia chinensis . J Nat Prod 1997; 60: 904-908
• 14 Bruggisser R, von Daeniken K, Jundt G, Schaffner W, Tullberg-Reinert H. Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay. Planta Med 2002; 68: 445-448
• 15 Gong JP, Traganos F, Darzynkiewicz Z. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 1994; 218: 314-319
• 16 Yang LL, Chang CC, Chen LG, Wang CC. Antitumor principle constituents of Myrica rubra var. acuminata . J Agric Food Chem 2003; 51: 2974-2979